Selenium deficiency associated with anemia among hospitalized heart failure patients

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-02-02 05:15 GMT   |   Update On 2024-02-02 07:06 GMT

A recent study published in the ESC Heart Failure highlights the intricate relationship between selenium levels and anemia in heart failure (HF) patients. Based on the findings from the BIOSTAT-CHF study, the research reveals important insights into how selenium deficiency contributes to the severity of anemia in individuals with heart failure.Heart failure patients usually face a...

Login or Register to read the full article

A recent study published in the ESC Heart Failure highlights the intricate relationship between selenium levels and anemia in heart failure (HF) patients. Based on the findings from the BIOSTAT-CHF study, the research reveals important insights into how selenium deficiency contributes to the severity of anemia in individuals with heart failure.

Heart failure patients usually face a challenging prognosis, with increased hospitalization rates, decreased exercise tolerance and higher mortality. But, this new study underlines the significance of selenium in reducing these adverse outcomes. The study was conducted on 320 hospitalized HF subjects and found that higher levels of selenoprotein P (SELENOP) which is a crucial biomarker for selenium transport, were associated with a lower risk of anemia and iron deficiency.

The comprehensive analysis considered SELENOP concentrations in relation to hemoglobin (Hb) levels, the prevalence of anemia and iron status, as measured by the transferrin receptor 1 (TfR1). The results revealed a clear correlation between SELENOP levels and these crucial health markers.

It was also discovered that SELENOP concentrations were positively correlated with hemoglobin concentrations which provides evidence that adequate selenium levels may positively influence blood health. However, SELENOP deficiency was associated with lower hemoglobin concentrations, higher TfR1 concentrations indicative of iron deficiency and a higher risk of anemia in HF patients.

These findings emphasize the role of selenium in the overall health management of the heart failure patients. SELENOP appears to be a critical player in widely reducing the risk of anemia and targeted interventions to improve the patient outcomes. This research deepens our understanding of the potential connections between selenium, anemia and heart failure and additionally paves the way for future interventions by optimizing selenium levels in HF patients that could improve their overall prognosis. 

Reference:

Jujić, A., Molvin, J., Holm Isholth, H., Dieden, A., Korduner, J., Zaghi, A., Nezami, Z., Bergmann, A., Schomburg, L., & Magnusson, M. (2024). Association between low selenoprotein P concentrations and anaemia in hospitalized heart failure patients. ESC Heart Failure. https://doi.org/10.1002/ehf2.14651

Tags:    
Article Source : ESC Heart Failure

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News